Aspirin Versus Clopidogrel Monotherapy for the Treatment of Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Aspirin Versus Clopidogrel Monotherapy for the Treatment of Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis ; volume:36 ; number:8 ; day:1 ; month:6 ; year:2019 ; pages:2062-2071 ; date:8.2019
Advances in therapy ; 36, Heft 8 (1.6.2019), 2062-2071, 8.2019
- Urheber
-
Yuan, Jun
Xu, Guang Ma
Ding, Jiawang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-019-01004-6
- URN
-
urn:nbn:de:101:1-2019121823204588556232
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yuan, Jun
- Xu, Guang Ma
- Ding, Jiawang
- SpringerLink (Online service)
Ähnliche Objekte (12)
![The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]](/assets/placeholder/searchResultMediaUnknown.png)
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
A retrospective study of the safety and efficacy of clopidogrel versus aspirin monotherapy one year after coronary stent implantation
Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel
High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance
Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
P2Y12 blocker monotherapy after percutaneous coronary intervention
Residuelle Thrombozytenreaktivität in Aspirin und Clopidogrel behandelten Patienten nach interventionellem PFO/ASD Verschluss
Measurement of platelet function in an experimental stroke model with aspirin and clopidogrel treatment
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
A retrospective study of the safety and efficacy of clopidogrel versus aspirin monotherapy one year after coronary stent implantation
Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel
High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance
Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
P2Y12 blocker monotherapy after percutaneous coronary intervention
Residuelle Thrombozytenreaktivität in Aspirin und Clopidogrel behandelten Patienten nach interventionellem PFO/ASD Verschluss
Measurement of platelet function in an experimental stroke model with aspirin and clopidogrel treatment
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
A retrospective study of the safety and efficacy of clopidogrel versus aspirin monotherapy one year after coronary stent implantation
Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel
High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance
Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
P2Y12 blocker monotherapy after percutaneous coronary intervention
Residuelle Thrombozytenreaktivität in Aspirin und Clopidogrel behandelten Patienten nach interventionellem PFO/ASD Verschluss